Skip to content

Clinical trials

Fallopian Tube Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Country / region: Taiwan Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20111
20183
20191
20202
20221
20241
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Completed4
Terminated4
Active, not recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
AstraZeneca2
AbbVie1
Amgen1
CanariaBio Inc.1
Daiichi Sankyo1
Eli Lilly and Company1
GlaxoSmithKline1
Mural Oncology, Inc1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms18
Ovarian Neoplasms15
Carcinoma, Ovarian Epithelial6
Peritoneal Neoplasms3
Neoplasms2
Carcinoma1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Squamous Cell1
Colorectal Neoplasms1
Endometrial Neoplasms1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.